相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prolonged viral suppression with anti-HIV-1 antibody therapy
Christian Gaebler et al.
NATURE (2022)
Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins manufactured from Post-COVID-19 and COVID-19-Vaccinated Plasma Donations
Michael Karbiener et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
L. Corey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Elimination of SHIV Infected Cells by Combinations of Bispecific HIVxCD3 DART(R) Molecules
Marina Tuyishime et al.
FRONTIERS IN IMMUNOLOGY (2021)
Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial
Sarah Fidler et al.
LANCET (2020)
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo
Christopher C. Nixon et al.
NATURE (2020)
Enhancing natural killer cell function with gp41-targeting bispecific antibodies to combat HIV infection
Nitya S. Ramadoss et al.
AIDS (2020)
Curing HIV: Seeking to Target and Clear Persistent Infection
David M. Margolis et al.
CELL (2020)
Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection
Cynthia L. Gay et al.
SCIENTIFIC REPORTS (2020)
Redirection of Cord Blood T Cells and Natural Killer Cells for Elimination of Autologous HIV-1-Infected Target Cells Using Bispecific DART® Molecules
Justin Pollara et al.
FRONTIERS IN IMMUNOLOGY (2020)
Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodies
Marina Tuyishime et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIVCCH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques
Amir Dashti et al.
JOURNAL OF VIROLOGY (2020)
CD8+ T cells in HIV control, cure and prevention
David R. Collins et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Concurrent Exposure of Neutralizing and Non-neutralizing Epitopes on Single HIV-1 Envelope Structure
Krishanu Ray et al.
FRONTIERS IN IMMUNOLOGY (2019)
Bispecific T-cell engagers: Towards understanding variables influencing the in vitro potency and tumor selectivity and their modulation to enhance their efficacy and safety
Diego Ellerman
METHODS (2019)
HIV-1 latent reservoir size and diversity are stable following brief treatment interruption
D. Brenda Salantes et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs
Johannes Brozy et al.
JOURNAL OF VIROLOGY (2018)
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections
Kshitij Wagh et al.
PLOS PATHOGENS (2018)
Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies
Bushra Husain et al.
BIODRUGS (2018)
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
Pilar Mendoza et al.
NATURE (2018)
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
Yotam Bar-On et al.
NATURE MEDICINE (2018)
Survivors Remorse: antibody-mediated protection against HIV-1
George K. Lewis et al.
IMMUNOLOGICAL REVIEWS (2017)
Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir
Shariq Mujib et al.
JOURNAL OF VIROLOGY (2017)
Early antibody therapy can induce long-lasting immunity to SHIV
Yoshiaki Nishimura et al.
NATURE (2017)
Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge
Todd Bradley et al.
NATURE COMMUNICATIONS (2017)
One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells
Wei Li et al.
SCIENTIFIC REPORTS (2017)
Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity
Luzia M. Mayr et al.
SCIENTIFIC REPORTS (2017)
Depletion of Gut-Resident CCR5+ Cells for HIV Cure Strategies
David Merriam et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2017)
CD8+ Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy
Emily K. Cartwright et al.
IMMUNITY (2016)
Towards HIV-1 remission: potential roles for broadly neutralizing antibodies
Ariel Halper-Stromberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors
Hongbing Yang et al.
MOLECULAR THERAPY (2016)
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
Johannes F. Scheid et al.
NATURE (2016)
Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control
Margaret E. Ackerman et al.
PLOS PATHOGENS (2016)
Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer
Adam R. Root et al.
ANTIBODIES (2016)
A Novel HIV Envelope Bi-Specific Killer Engager Enhances Natural Killer Cell Mediated ADCC Responses Against HIV-Infected Cells
Zachary B. Davis et al.
BLOOD (2016)
Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells
Julia A. M. Sung et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Marina Caskey et al.
NATURE (2015)
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
Rebecca M. Lynch et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Activation and lysis of human CD4 cells latently infected with HIV-1
Amarendra Pegu et al.
NATURE COMMUNICATIONS (2015)
Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells
Derek D. Sloan et al.
PLOS PATHOGENS (2015)
Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice
Ariel Halper-Stromberg et al.
CELL (2014)
Interaction with Cellular CD4 Exposes HIV-1 Envelope Epitopes Targeted by Antibody-Dependent Cell-Mediated Cytotoxicity
Maxime Veillette et al.
JOURNAL OF VIROLOGY (2014)
Antibody biodistribution coefficients Inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human
Dhaval K. Shah et al.
MABS (2013)
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
Dan H. Barouch et al.
NATURE (2013)
High Antibody-Dependent Cellular Cytotoxicity Responses Are Correlated with Strong CD8 T Cell Viral Suppressive Activity but Not with B57 Status in HIV-1 Elite Controllers
Olivier Lambotte et al.
PLOS ONE (2013)
Unravelling the mechanisms of durable control of HIV-1
Bruce D. Walker et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma
Paul A. Moore et al.
BLOOD (2011)
Fitness Costs and Diversity of the Cytotoxic T Lymphocyte (CTL) Response Determine the Rate of CTL Escape during Acute and Chronic Phases of HIV Infection
Vitaly V. Ganusov et al.
JOURNAL OF VIROLOGY (2011)
Relationship between Functional Profile of HIV-1 Specific CD8 T Cells and Epitope Variability with the Selection of Escape Mutants in Acute HIV-1 Infection
Guido Ferrari et al.
PLOS PATHOGENS (2011)
Heterogeneous neutralizing antibody and anti body-dependent cell cytotoxicity responses in HIV-1 elite controllers
Olivier Lambotte et al.
AIDS (2009)
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection
Nilu Goonetilleke et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection
G. Alter et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD4+ T Cells
Hendrik Streeck et al.
JOURNAL OF VIROLOGY (2009)
HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently
Emma L. Turnbull et al.
JOURNAL OF IMMUNOLOGY (2006)
Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1
PL Moore et al.
JOURNAL OF VIROLOGY (2006)
The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs inVL-to-VH orientation:: Implications for diabody flexibility
JA Carmichael et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy
A Valentin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion
CM Finnegan et al.
JOURNAL OF VIROLOGY (2001)
分享论文
